JP2022536669A5 - - Google Patents

Info

Publication number
JP2022536669A5
JP2022536669A5 JP2021573344A JP2021573344A JP2022536669A5 JP 2022536669 A5 JP2022536669 A5 JP 2022536669A5 JP 2021573344 A JP2021573344 A JP 2021573344A JP 2021573344 A JP2021573344 A JP 2021573344A JP 2022536669 A5 JP2022536669 A5 JP 2022536669A5
Authority
JP
Japan
Application number
JP2021573344A
Other languages
Japanese (ja)
Other versions
JP2022536669A (ja
JPWO2020249577A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/066003 external-priority patent/WO2020249577A1/en
Publication of JP2022536669A publication Critical patent/JP2022536669A/ja
Publication of JPWO2020249577A5 publication Critical patent/JPWO2020249577A5/ja
Publication of JP2022536669A5 publication Critical patent/JP2022536669A5/ja
Pending legal-status Critical Current

Links

JP2021573344A 2019-06-12 2020-06-10 Smaの新規治療 Pending JP2022536669A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19179563 2019-06-12
EP19179563.2 2019-06-12
PCT/EP2020/066003 WO2020249577A1 (en) 2019-06-12 2020-06-10 New treatment of sma

Publications (3)

Publication Number Publication Date
JP2022536669A JP2022536669A (ja) 2022-08-18
JPWO2020249577A5 JPWO2020249577A5 (https=) 2023-06-16
JP2022536669A5 true JP2022536669A5 (https=) 2023-06-16

Family

ID=66826852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573344A Pending JP2022536669A (ja) 2019-06-12 2020-06-10 Smaの新規治療

Country Status (5)

Country Link
US (1) US20220168307A1 (https=)
EP (1) EP3982970A1 (https=)
JP (1) JP2022536669A (https=)
CN (1) CN113966219A (https=)
WO (1) WO2020249577A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4197536A1 (en) * 2021-12-20 2023-06-21 Universitat de València Haloperidol for use in the treatment of spinal muscular atrophy
CN117250301B (zh) * 2023-11-20 2024-02-09 中国医学科学院北京协和医院 一种定量检测人血浆中诺西那生的液相质谱联用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130964D0 (en) 2001-12-24 2002-02-13 Special Products Ltd Pharmaceutical composition
ES2761423T3 (es) 2014-05-15 2020-05-19 Hoffmann La Roche Compuestos para tratar la atrofia muscular espinal
EA036399B1 (ru) 2015-11-12 2020-11-06 Ф. Хоффманн-Ля Рош Аг Композиции для лечения спинальной мышечной атрофии
EP3691647A1 (en) * 2017-10-03 2020-08-12 H. Hoffnabb-La Roche Ag New treatment of sma

Similar Documents

Publication Publication Date Title
JP2022536669A5 (https=)
CN306401934S (https=)
CN306371891S (https=)
CN305813125S (https=)
CN305815007S (https=)
CN305822350S (https=)
CN305926082S (https=)
CN305930371S (https=)
CN305930603S (https=)
CN305974195S (https=)
CN306155177S (https=)
CN306157805S (https=)
CN306158568S (https=)
CN306158619S (https=)
CN306158865S (https=)
CN306163841S (https=)
CN306189166S (https=)
CN306197192S (https=)
CN306199075S (https=)
CN306201485S (https=)
CN306202693S (https=)
CN306202829S (https=)
CN306256232S (https=)
CN306257074S (https=)
CN306264890S (https=)